行情

VSTM

VSTM

Verastem
NASDAQ

实时行情|Nasdaq Last Sale

1.480
+0.010
+0.00%
盘后: 1.470 -0.01 -0.68% 19:55 08/07 EDT
开盘
1.490
昨收
1.480
最高
1.519
最低
1.460
成交量
219.63万
成交额
--
52周最高
4.670
52周最低
0.8300
市值
2.41亿
市盈率(TTM)
-0.8060
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测VSTM价格均价为3.833,最高价位5.00,最低价为3.000。

EPS

VSTM 新闻

更多
Verastem (VSTM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Verastem (VSTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:34
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · 07/06 12:00
Hedge Funds Never Loved Verastem Inc (VSTM) More
In this article we will take a look at whether hedge funds think Verastem Inc (NASDAQ:VSTM) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on I
Insider Monkey · 06/24 03:07
Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of VS-6766 and Defactinib in Metastatic Uveal Melanoma
Business Wire · 06/22 21:05
Verastem Oncology Highlights Presentation Of Preclinical Data Supporting Combo Of VS-6766, Defactinib In Metastatic Uveal Melanoma
Verastem, Inc. (NASDAQ:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced results from a study
Benzinga · 06/22 20:07
Verastem Oncology to Present at the Jefferies Virtual Healthcare Conference
Business Wire · 05/28 12:00
Billionaire Steven Cohen Bets Big on These 3 Stocks
TipRanks · 05/19 14:47
Are Options Traders Betting on a Big Move in Verastem (VSTM) Stock?
Zacks · 05/18 16:20

所属板块

生物技术和医学研究
-0.18%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

VSTM 简况

Verastem Inc是一家生物制药公司。该公司从事开发和商业化用来改善癌症病人病情的药物。该公司运营开发治疗癌症药物的分部。该公司已经面向市场和正在开发的产品包括COPIKTRA(Duvelisib)和defactinib,其项目包括CH5126766,也称为VS-6766。Defactinib是粘着斑激酶(FAK)的靶向抑制剂。粘着斑激酶是一种非受体酪氨酸激酶,由参与细胞黏附和癌症转移的PTK-2基因编码。该公司从事针对治疗方案有限的癌症进行临床试验,包括白血病、淋巴瘤、肺癌、间皮瘤、卵巢癌、头颈癌、结肠直肠癌和胰腺癌。
展开

微牛提供Verastem Inc(NASDAQ-VSTM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的VSTM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易VSTM股票基本功能。